A required part of this site could not load. This could be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
A required part of this site could not load. This could be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
Douglas Rissing Recursion pharmaceuticals (RXRX) added ~11% on Wednesday morning after JP Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing blockbuster sales potential for the company’s lead asset,…
In today’s luxury housing market, it’s becoming increasingly difficult to sell for what the homeowner thinks the home is worth—and even high-profile sellers forced to lower the price of their…

